4Eucker J, Sezer O, Graf B, et al. Mucormycoses [ J]. Mycoses, 2001, 44 (7/8): 253-260.
5Talmi YP, Goldschmeid - Reouven A, Bakon M, et al. Rhino - orbital and rhino - orbito - cerebral mucormycosis [ J ]. Otolaryngol Head NeckSurg, 2002, 127 (1): 22-31.
6Ellis M. Invasive fungal infections: evolving challenges for diagnosis and therapeutics [ J]. Mol Immunol, 2001, 38 (12/13) : 947 - 957.
8Segal BH, Almyroudis NG, Battiwalla M, et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad - spectrum antifungal agents and diagnostic adjuncts [ J]. Clin Infect Dis, 2007, 44 (3): 402-409.
9Gomez - Lopez A, Cuenca - Estrella M, Monzon A, et al. In vitro susceptibility of clinical isolates of zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole [ J J. J Antimicrob Chemother, 2001, 48 (6): 919-921.
10Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management [ J ]. Clin Microbiol Rev, 2005, 18 (3): 556-569.
